Neximmune Price on July 9, 2024

NEXIDelisted Stock  USD 2.43  0.22  9.95%   
If you're considering investing in Neximmune Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Neximmune stands at 2.43, as last reported on the 26th of November, with the highest price reaching 2.59 and the lowest price hitting 2.15 during the day. We have found twenty-four technical indicators for Neximmune, which you can use to evaluate the volatility of the firm. Please verify Neximmune's Standard Deviation of 10.32, risk adjusted performance of (0.01), and Mean Deviation of 4.85 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Neximmune Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NEXI
Based on monthly moving average Neximmune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neximmune by adding Neximmune to a well-diversified portfolio.

Related Headline

ZyVersa Therapeutics Headline on 9th of July 2024

ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies Phase 2a Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for treatment of obesity and its associated metabolic complications, among other inflammatory diseases.Mr. Glover welcomes one-on-one meetings with registered participants. WESTON, Fla., July 09, 2024 -- ZyVersa Therapeutics, Inc. Nasdaq

Neximmune Valuation on July 9, 2024

It is possible to determine the worth of Neximmune on a given historical date. On July 9, 2024 Neximmune was worth 2.44 at the beginning of the trading date compared to the closed value of 2.28. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neximmune pink sheet. Still, in general, we apply an absolute valuation method to find Neximmune's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neximmune where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neximmune's related companies.
 Open High Low Close Volume
  2.31    2.46    2.31    2.39    8,581  
07/09/2024
  2.44    2.44    2.25    2.28    20,207  
  2.25    2.43    2.01    2.31    49,410  
Backtest Neximmune  |  Neximmune History  |  Neximmune Valuation   PreviousNext  
Open Value
2.44
2.28
Closing Value
2.44
Upside

Neximmune Trading Date Momentum on July 9, 2024

On July 10 2024 Neximmune was traded for  2.31  at the closing time. The top price for the day was 2.43  and the lowest listed price was  2.01 . The trading volume for the day was 49.4 K. The trading history from July 10, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 1.32% . The trading delta at closing time against the current closing price is 3.07% .

Neximmune Fundamentals Correlations and Trends

By evaluating Neximmune's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neximmune's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neximmune financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Neximmune Pink Sheet history

Neximmune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neximmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neximmune will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neximmune stock prices may prove useful in developing a viable investing in Neximmune
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. Neximmune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.

Neximmune Pink Sheet Technical Analysis

Neximmune technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Neximmune technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neximmune trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Neximmune Period Price Range

Low
November 26, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Neximmune cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Neximmune November 26, 2024 Market Strength

Market strength indicators help investors to evaluate how Neximmune pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neximmune shares will generate the highest return on investment. By undertsting and applying Neximmune pink sheet market strength indicators, traders can identify Neximmune entry and exit signals to maximize returns

Neximmune Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neximmune's price direction in advance. Along with the technical and fundamental analysis of Neximmune Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neximmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Neximmune Pink Sheet

If you are still planning to invest in Neximmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neximmune's history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA